Drug Approval | August 28, 2022
Cipla receives 6 observations from USFDA for Goa facility
There are no data integrity (DI) observations.
There are no data integrity (DI) observations.
Strengthens investment in channels of the future to expand patient reach
A total of five observations for Goa and 17 for Monroe
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
FDA changes inspection classification of the facility to Voluntary Action Indicated
The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
This is an exciting and meaningful milestone for GRIN Therapeutics
Subscribe To Our Newsletter & Stay Updated
